![]() | ![]() |
Formats:
|
||||||||||||||||
Copyright © 2009 Bruant et al; licensee BioMed Central Ltd. Two distinct groups of porcine enteropathogenic Escherichia coli strains of serogroup O45 are revealed by comparative genomic hybridization and virulence gene microarray 1Groupe de Recherche sur les Maladies Infectieuses du Porc, Faculté de médecine vétérinaire, Université de Montréal, 3200 rue Sicotte, Saint-Hyacinthe, Québec J2S 7C6, Canada 2Laboratory for Foodborne Zoonoses, Public Health Agency of Canada, Lethbridge, Alberta, T1J 3Z4, Canada Corresponding author.#Contributed equally. Guillaume Bruant: guillaume.bruant/at/nrc-cnrc.gc.ca; Yongxiang Zhang: Yongxiang.Zhang/at/inspection.gc.ca; Philippe Garneau: philippe.garneau/at/umontreal.ca; Justin Wong: justin/at/brc.ubc.ca; Chad Laing: Chad.Laing/at/inspection.gc.ca; John M Fairbrother: john.morris.fairbrother/at/umontreal.ca; Victor PJ Gannon: Vic.Gannon/at/inspection.gc.ca; Josée Harel: josee.harel/at/umontreal.ca Received April 23, 2009; Accepted August 26, 2009. This is an Open Access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited. Abstract Background Porcine enteropathogenic Escherichia coli (PEPEC) strains of serogroup O45 cause post-weaning diarrhea and produce characteristic attaching and effacing (A/E) lesions. Most O45 PEPEC strains possess the locus of enterocyte effacement (LEE), encoding the virulence factors required for production of A/E lesions, and often possess the paa gene, which is thought to contribute to the early stages of PEPEC pathogenicity. In this study, nine O45 PEPEC strains and a rabbit enteropathogenic (REPEC) strain, known to produce A/E lesions in vivo, were characterized using an E. coli O157-E. coli K12 whole genome microarray and a virulence gene-specific microarray, and by PCR experiments. Results Based on their virulence gene profiles, the 10 strains were considered to be atypical EPEC. The differences in their genomes pointed to the identification of two distinct evolutionary groups of O45 PEPEC, Groups I and II, and provided evidence for a contribution of these genetic differences to their virulence in pigs. Group I included the REPEC strain and four O45 PEPEC strains known to induce severe A/E lesions in challenged pigs whereas Group II was composed of the five other O45 PEPEC strains, which induced less severe or no A/E lesions in challenged pigs. Significant differences between Groups I and II were found with respect to the presence or absence of 50 O-Islands (OIs) or S-loops and 13 K-islands (KIs) or K-loops, including the virulence-associated islands OI#1 (S-loop#1), OI#47 (S-loop#71), OI#57 (S-loop#85), OI#71 (S-loop#108), OI#115, OI#122, and OI#154 (S-loop#253). Conclusion We have genetically characterized a collection of O45 PEPEC strains and classified them into two distinct groups. The differences in their virulence gene and genomic island content may influence the pathogenicity of O45 PEPEC strains, and explain why Group I O45 PEPEC strains induced more severe A/E lesions in explants and challenged pigs than Group II strains. Background Escherichia coli of serogroup O45 may be isolated both in intestinal and extraintestinal sites, although they have been only sporadically described in the latter [1-3]. On the other hand, intestinal E. coli strains have been more frequently identified as belonging to this serogroup. Intestinal O45 E. coli strains have been isolated from animals and humans and have been classified as both enterotoxigenic (ETEC) and attaching and effacing (AEEC) E. coli, the latter including both enterohemorrhagic (EHEC) and enteropathogenic (EPEC) E. coli [4-6]. Serogroup O45 is particularly important among porcine EPEC (PEPEC) strains which cause post-weaning diarrhea (PWD) characterized by specific attaching and effacing (A/E) lesions [7-9]). Most O45 PEPEC strains possess the locus of enterocyte effacement (LEE) pathogenicity island, which contains virulence genes necessary for the production of A/E lesions. They also often possess the paa gene (for porcine A/E associated gene), which encodes a virulence factor involved in the A/E phenotype and is thought to contribute to the early stages of PEPEC pathogenicity [10]. These strains also have the ability to produce A/E lesions in experimentally inoculated newborn gnotobiotic piglets and in a homologous in vitro model using newborn piglet ileal explants, as well as to adhere to PK15 porcine kidney cells in vitro [10-14]. Genomic islands (GIs) such as LEE are regions of bacterial genomes that have been acquired by horizontal gene transfer and often contain blocks of genes that function together in specific processes. When the genomes of the two E. coli O157:H7 strains EDL933 and Sakai were compared with that of E. coli K12 strain MG1655, the GIs found to be present in strains EDL933 and Sakai but absent in strain MG1655 were named O-islands (OIs) and Sakai loops (S-loops), respectively. The GIs found to be present in E. coli K12 but absent from the two E. coli O157:H7 strains were named K-islands (KIs) and K-loops, respectively [15-17]. GIs related to the virulence of a pathogen are also referred to as pathogenicity islands (PAIs) [18]. In E. coli O157:H7 strain EDL933, several large OIs encode virulence or putative virulence factors. These OIs include OI#45 (S-loop#69) and OI#93 (S-loop#153) for Shiga toxin 2 and 1, respectively, OI#148 (S-loop#244) for LEE, and OI#57 (S-loop#85) for paa [16,17]. A recent microarray-based study has catalogued genomic alterations in a collection of E. coli O157:H7 strains, particularly in GIs, suggesting the existence of two dominant lineages, with characteristics that are unique to each of them [19]. Previous studies performed on various AEEC strains have also shown that, depending on their pathotype and host specificity, strains can show variations in their LEE sequences as well as in the site of insertion of LEE in the chromosome [14,20,21]. The purpose of the present study was to examine the genotypic differences, particularly in LEE sequences and chromosomal insertion sites, and in the presence or absence of non LEE-encoded virulence factors, such as Paa, among a collection of O45 PEPEC strains which have been previously shown to induce A/E lesions in pigs. In this study, we have characterized O45 PEPEC strains using a DNA-microarray designed specifically for detection of E. coli virulence genes [22] and compared their genomes using comparative genomic hybridization (CGH) and PCR. We identified two distinct groups of PEPEC O45 strains, between which there were significant variations in GI content. Methods Bacterial strains and preparation of genomic DNA Nine O45 PEPEC strains, which were isolated at the Faculté de médecine vétérinaire, Saint-Hyacinthe, Québec, Canada, from pigs with PWD [13] were used for the microarray studies (Table 1). These strains were selected based, i) on their ability to produce or not A/E lesions in challenged pigs [13] and in an homologous ex vivo model using newborn piglet ileal explants (data not shown), ii) and on the severity of the A/E manifestation they produced [13] (Table 1). Because of its genetic and phenotypic similarities with the O45 PEPEC strains [23], the O103 rabbit EPEC (REPEC) strain E22, provided by Eric Oswald (INRA, Toulouse, France) [24,25], was included in the study. Five E. coli reference strains were used as controls in PCR experiments: the two O157:H7 E. coli strains EDL933 and Sakai, the K12 strain MG1655, the uropathogenic (UPEC) strain CFT073 and the REPEC strain RDEC-1.
For DNA preparations, strains were grown overnight in 45 mL of Brain-Heart-Infusion (BHI) broth at 37°C. The cultures were centrifuged at 8000 rpm for 10 minutes and the pellet was dissolved in 15 mL of 10 mM NaCl, 20 mM Tris-HCl (pH 8.0), 1 mM EDTA, 100 μg/mL proteinase K and 0.5% SDS. This suspension was incubated at 50°C for 2 h and DNA was extracted with an equal volume of phenol:chloroform:isoamyl alcohol (25:24:1). Following centrifugation for 10 min at 8000 rpm, the upper phase was removed and precipitated by adding 0.1 volume of 3 M NaOAc (pH 5.2) and 2 volumes of 99% ethanol. The DNA precipitate was then spooled out of the solution using a sterile glass rod, washed with 70% ethanol, and dissolved in 5 mL of TE (10 mM Tris-HCl, 1 mM EDTA, pH 8.0) buffer. E. coli DNA microarrays For the whole genome microarray (named E. coli O157:H7 microarray), Corning Ultra-Gap II slides (Corning, Acton, MA) were spotted with the MWG E. coli O157:H7 array set (MWG Biotech). The MWG array set consists of 6167 50-mer oligonucleotides covering the whole genomes of E. coli K-12 strain MG1655 [15] and E. coli O157:H7 strains Sakai (RIMD 0509952) [16] and EDL933 (ATCC700927) [17]. The E. coli virulence microarray used in this study was derived from the one previously developed by Bruant et al. and included 315 70-mer oligonucleotides specific for 189 E. coli virulence or putative virulence genes or markers found in various intestinal and extraintestinal E. coli strains of all known pathotypes [22]. Probes were specific for genes encoding adhesins; toxins; bacteriocins; anti-aggregative factors; autotransporters; capsular, flagellar, and somatic antigens; hemolysins; invasins; iron acquisition systems or transport proteins; and outer membrane proteins, as well as other genes recently shown to be associated with virulence in E. coli. This microarray also detected genetic variants of particular genes, such as the intimin-encoding gene eae (variants alpha, alpha2, beta, beta2, delta, epsilon, epsilon2, eta, gamma, gamma2, iota, iota2, lambda, mu, nu, pi, xi, and zeta), espA (variants espA1, espA2, and espA3), espB (variants espB1, espB2, and espB3), and tir (variants tir-1, tir-2, and tir-3) from the LEE. Oligonucleotides specific for three variants of the major fimbrial subunit of the long polar fimbria (LPF)-encoding gene lpfA were also included. These were based on sequences from the lpfA genes of EPEC strains of serogroup O113 (lpfAO113), OI#141 from E. coli of serotype O157:H7 (lpfA1), and REPEC strains and E. coli of serogroup O26 (lpfAR141). Microarray hybridizations Prior to E. coli O157:H7 microarray hybridization, each array was pre-hybridized at 50°C in a solution of 5 × SSC, 0.1% SDS and 0.1% BSA for 1 h. Following this step, arrays were washed completely in dH2O, rinsed with isopropanol, and then centrifuged and dried. For hybridization, 5 μg of test genomic DNA were digested with EcoRV and PstI restriction enzymes, 3 μg of which were labeled with ULYSIS Alexa Fluor 647 dye (Invitrogen, Burlington, ON). Genomic DNA from strains MG1655, Sakai and EDL933 was digested in an analogous fashion, and 1 μg of the preparation from each strain was combined and labeled with Alexa Fluor 546 dye (Invitrogen, Burlington, ON). This labeled genomic DNA mixture was then used as a reference for all hybridizations. Unincorporated dye was removed using Qiaquick PCR purification kits (Qiagen, Mississauga, ON), according to the manufacturer's instructions, and DNA was eluted in 30 μl of 0.1 × TE buffer. Labeled DNA was vacuum-dried and resuspended in 20 μl of dH2O. A 70 μl hybridization solution consisting of 30% formamide, 5 × SSC, 0.1% SDS, 0.1 mg/ml sonicated Salmon sperm DNA, and equal amounts of test and reference labeled DNAs, each containing at least 30 pmol of incorporated dye, was denatured at 95°C for 5 min and briefly centrifuged to collect all the contents. DNA preparations were then hybridized overnight (16 h) at 42°C. After hybridization, arrays were washed according to the modified Corning method (Corning). Arrays were then scanned with a GenePix 4000B scanner (Axon Instruments, Redwood City, CA) and processed using GenePix Pro 5.0. Two slides were hybridized per strain with a dye-swap repeat per slide. Hybridizations on E. coli virulence microarrays were performed as described previously [22]. Arrays were scanned with a ScanArray® Lite fluorescent microarray analysis system (Canberra-Packard Canada, Montreal, Quebec) and acquisition and quantification of fluorescent spot intensities were performed using the ScanArray Express® software version 2.1 (Perkin-Elmer, Foster City, CA, USA). Microarray data analysis Data obtained from E. coli O157:H7 microarrays were normalized using the Ratio-based and Lowess methods in Acuity 3.1 (Axon instruments) before analysis. The normalized data for all strains were converted into log2 (Fluor 647/Fluor 546) in Acuity 3.1 and subsequently analyzed in Microsoft Excel. Control, blank, and test spots with a mean intensity below that of the mean of all negative controls were removed from the analysis. The arithmetic mean of the remaining spots across the four duplicates was calculated to construct the dataset. GACK (for Genomotyping Analysis by Charles Kim) [26], was used to generate a cut-off value determining the presence or absence of genes, and a dendrogam using the Euclidean distance metric with average linkage was created with tMEV v4.1 [27]. For the data obtained from E. coli virulence microarrays, the local background was subtracted from the recorded spot intensities. The median value of each set of triplicate spotted oligonucleotides was then compared to the median value of the negative control spots present on the array. Oligonucleotides with a signal-to-noise fluorescence ratio greater than 2.0 were considered as positive. Microarray data accession number The microarray data have been deposited in NCBI's Gene Expression Omnibus (GEO accession number GSE17036) http://www.ncbi.nlm.nih.gov/projects/geo/. PCR experiments PCR experiments were performed for the nine O45 PEPEC strains and the REPEC strain E22 to determine the localization in their chromosome of the LEE and of the OI#122, as well as the integrity of the OI#122 and of the secondary type III secretion system gene cluster designated ETT2 (for E. coli type III secretion 2). All PCR experiments were performed as described in previous studies carried out on the LEE, OI#122 and ETT2 gene clusters (Additional file 1: Table S1 [21,23,28-31]). PCR experiments were also performed for nleA and nleC genes. The pairs of primers used were nleA-F (ACCGCAATCCGAATTACCTC) – nleA-R (TCCATTGCGCGTATATCAGC) and ECs1812F (CTGTCCAACAGGGATAC) – ECs1812R (CCGCAATCCGAATTACC) for nleA, and nleC-F (AAGTGTAATACGCGCCGTCC) – nleC-R (ATCAGGACTCGCCTCATATC) and ECs0847F (CCCATTGCTCCTAATCG) – ECs0847R (CAGCGGAATACTCTGTG) for nleC. The conditions for amplifications were an initial denaturation of 95°C for 5 min, followed by 30 cycles of 95°C for 30 s; 55°C for 30 s; 72°C for 80 s and a final elongation of 72°C for 10 min. Results Characterization of O45 PEPEC strains using the E. coli virulence microarray All O45 PEPEC strains and the REPEC strain E22 were characterized using the E. coli virulence microarray described previously, which includes probes targeting virulence genes generally found in AEEC but also virulence genes from the other E. coli virotypes [22]. All strains possessed their own specific virulence gene profile but were all classified as atypical EPEC (Additional file 2: Table S2 [32]). They all possessed the LEE genes and shared the same LEE profile: eae(β) – espA group I – espB group III – tir group I. In addition, each strain lacked the Shiga toxin 2 encoding genes stx2A and stx2B, as well as the bundle forming pili (BFP) encoding gene bfpA and the E. coli adherence factor (EAF) virulence plasmid marker eaf. Remarkably, all O45 PEPEC strains and REPEC strain E22, although stx1A-negative, gave a positive hybridization for the stx1B gene, which encodes the B subunit of EHEC Shiga-like toxin 1 and which is generally absent in EPEC strains. However, the presence of the stx1B gene was not confirmed in PCR experiments (data not shown). The E. coli strains could be classified into two distinct groups according to their virulence gene pattern (Additional file 2: Table S2 [32]). Group I included the four PEPEC strains ECL1001, ECL2004, ECL2017, and ECL2033, and REPEC strain E22. Group II included the five other PEPEC strains ECL2019, ECL2020, ECL2027, ECL2076, and ECL2078. Results obtained with the E. coli virulence microarray identified 19 virulence genes that showed a non-random distribution between Group I and Group II strains (Additional file 2: Table S2 [32]). Genes b1121 (encoding a hypothetical protein YcfZ), set (encoding a probable enterotoxin, also named ent), tspE4.C2 (an anonymous fragment), efa1 (encoding the EHEC factor for adherence Efa1), and paa were present in all Group I strains, including REPEC strain E22, but absent from all Group II strains. The temperature sensitive hemagglutinin encoding gene tsh, the yersiniabactin-related genes fyuA, irp1 and irp2, as well as the PAI-associated gene malX were present in all O45 PEPEC strains from Group I but in neither REPEC strain E22 nor Group II strains. The heat-stable enterotoxin encoding gene astA was present in all O45 PEPEC Group I strains and in Group II strain ECL2020 but absent from all other Group II strains and REPEC strain E22. The genes aidaI (encoding the Adhesin Involved in E. coli Diffuse Adherence), chuA (an iron related gene), ECs1282 (encoding a probable filamentous hemagglutinin-like protein), rtx (encoding a putative RTX family exoprotein), and yjaA (encoding a hypothetical protein) were present in all Group II strains but absent from Group I strains, including REPEC strain E22. The gene fepC (encoding a ferric enterobactin transport ATP-binding protein) was present in three Group II strains (ECL2019, ECL2078 and ECL2027) but absent from all other strains. In addition, Group I and Group II strains possessed different variants of the fliC (encoding the flagellin major subunit) and lpfA genes. O45 PEPEC strains from Group I, including REPEC strain E22, possessed the fliC variant flmA54, whereas Group II strains possessed the fliC gene. Group I strains also possessed the lpfAO113 and lpfAR141 variants, whereas REPEC strain E22 only possessed the lpfAR141 variant, and Group II strains possessed the lpfA1 variant. Previous phylogenetic analyses have shown that most E. coli strains belonged to the four main phylogenetic groups A, B1, B2, and D. Whereas extraintestinal E. coli strains belong mainly to groups B2 and D, most commensal and diarrheogenic strains belong to group A and group B1 [33]. Determination of the phylogenetic groups of the O45 PEPEC strains and REPEC strain E22 was based on the presence or absence of the two genes chuA and yjaA, and the DNA fragment tspE4.C2, as described by Clermont et al. [32]. All Group I strains including REPEC strain E22 were classified in phylogenetic group B1 and all Group II strains were classified in phylogenetic group B2. CGH-Genomotyping of PEPEC strains The CGH-based genomotyping analysis of the nine O45 PEPEC strains and the REPEC strain E22 led to their classification into two distinct groups in the same distribution as observed by the E. coli virulence microarray. A dendrogram based on the analysis of the CGH data for O45 PEPEC strains and REPEC strain E22, as well as for the two O157:H7 strains Sakai and EDL933 is presented in Figure Figure1.1
In addition to the 63 GIs found to be significantly different between Group I and Group II strains, 26 other GIs were conserved in both Groups (Table 3). Eight of these GIs were KIs or K-loops and 18 were OIs or S-loops.
Finally, analysis of the E. coli O157:H7 microarray data indicated that the Shiga toxin encoding genes stx1 and stx2 could not be detected in any of the O45 PEPEC strains or in the REPEC strain E22, and that similarly, all strains were lacking both the tccp (ECs2715/Z3072) and tccp2 (ECs1126/Z1385) genes, which encode E. coli O157:H7 type III effector proteins that couple the intimin receptor Tir to the actin-cytoskeleton, and trigger actin polymerization [37-40]. Analysis of LEE by the E. coli O157:H7 microarray Thirty of the 41 genes on LEE (OI#148/S-loop#244) were found to be conserved among the O45 PEPEC strains, REPEC strain E22, and the two O157:H7 strains EDL933 and Sakai (Table 4). These included the effector-encoding genes espA, espF and espG, the regulator ler, and most of the genes of the type III secretion pathway such as sepL, escD, cesT, escN, escV, sepD, escC, cesD, escU, escT, escS, and escR. For the 11 remaining genes on LEE, no hybridization was observed in the O45 PEPEC strains and REPEC strain E22, possibly reflecting genetic divergences between these strains and the O157:H7 representative strains EDL933 and Sakai. These genes were the effector-encoding genes espB, espD, and espH, intimin and the translocated intimin receptor-encoding genes eae and tir, the genes of the type III secretion pathway sepQ, sepZ, and escJ, and the genes map, mpc (for multiple point controller) and Z5117.
Localization of LEE and OI#122 The LEE of AEEC strains is often inserted in the vicinity of the tRNA loci selC or pheU. Since it has been previously reported that the site of insertion of LEE in PEPEC strains could be either in selC or in pheU [23], the O45 PEPEC strains in our study and REPEC strain E22 were examined by PCR using primers specific for these two genes and for LEE extremities (Additional file 1: Table S1 [21,23,28-31]). The LEE was found to be inserted into the tRNA pheU locus in all examined strains. Remarkably, an amplicon of 500 bp longer than the expected size was also obtained with primers specific for LEE extremities and selC for strains ECL2033 and ECL2020 (Additional file 3: Table S3 [22]). Similarly, the localization and integrity of OI#122 was determined by PCR using primers described previously (Additional file 1: Table S1 [21,23,28-31]). All Group I strains possessed this GI and were positive for the four genes tested; efa1, ent, nleB, and nleE, with the latter two encoding non-LEE virulence factors. OI#122 was found to be inserted into the tRNA pheU locus in strain ECL2033 and into the tRNA pheV locus in strains ECL1001 and ECL2004. The site of insertion of this GI was not determined for strain ECL2017 or for REPEC strain E22. All Group II strains lacked OI#122 (Additional file 3: Table S3 [22]). nle genes in O45 PEPEC strains The E. coli O157:H7 microarray used in our CGH studies contains oligonucleotide probes specific for genes encoding non-LEE factors which have previously been associated with the pathogenicity of AEEC strains [34,41]. The nleA and nleC genes were present in all O45 PEPEC strains and REPEC strain E22 as determined by the O157:H7 microarray (Table 5). Nevertheless, PCR analysis using two different primer sets for each gene (Additional file 1: Table S1 [21,23,28-31]) revealed amplicons of various sizes in the different strains, showing that the nleA and nleC genes in Group I were different from those in Group II (data not shown).
Sixteen other nle genes showed non-random distributions between Group I and Group II strains (Table 5). The five genes espY3, espX2, espR1, espL3' (Z5199/ECs4642), and espL3' (Z5200/ECs4643) were absent in all Group I strains but present in Group II strains. On the other hand, the five genes espX7, espK, espL2, nleB1, and nleE were present in all Group I strains but absent in Group II strains. The four genes nleG2-1', espO1-2, nleG, and nleG9' were present in all Group I strains with the exception of REPEC strain E22, and absent in Group II strains. The gene nleB2-1 was present in all Group II strains and also in REPEC strain E22 but absent in the other Group I strains. The gene nleD was present in only two Group I strains, ECL2004 and ECL2033, and absent in all the other strains, including REPEC strain E22. Two additional nle genes, nleF and nleH, were present in all O45 PEPEC strains. nleH, but not nleF, was also present in REPEC strain E22 (Table 5). Distribution of ETT2 genes OI#115, initially described in E. coli of serotype O157:H7 and present in other EPEC and EHEC strains from animals and humans, contains the secondary type III secretion system gene cluster ETT2 [31,42,43]. CGH data analysis revealed that all Group II strains had the entire ETT2 locus comprising 36 genes, with the exception of strain ECL2019, which lacked most of this GI (Additional file 4: Table S4 [16]). In contrast, Group I strains possessed only a partially intact locus and the occurrence of the ETT2 genes was highly variable. Among the 36 ETT2 genes, strain ECL2033 possessed only 21, strain ECL2004 possessed 20, strain ECL1001 possessed 17, and strain ECL2017 possessed 15. Finally, REPEC strain E22 possessed 21 genes of this GI. These results were confirmed by PCR as described previously [31], with primers specific for different regions of the ETT2 gene cluster (Additional file 1: Table S1 [21,23,28-31]). Genes required for intestinal colonization in the bovine Previous studies have identified several genes required for EHEC intestinal colonization of the bovine [44,45]. Microarray analysis in our study revealed that 13 genes associated with colonization of either E. coli O157:H7 or E. coli O26:H- in the bovine were associated with either Group I or Group II strains (Additional file 5: Table S5). Seven genes were present in Group I but not in Group II strains, with the exception of REPEC strain E22 which did not possess the gene Z6010 (ECs1824). In contrast, six other genes were present in Group II but not in Group I strains, with the exception of REPEC strain E22 which possessed the gene Z1526 (ECs1270). These results were confirmed by PCR using primers designed for each gene (data not shown). Discussion In this study, we investigated the genetic relationships among PEPEC strains of serogroup O45 and catalogued genomic alterations unique to these strains by using both a virulence gene-specific microarray and a whole genome microarray. The 045 PEPEC strains in this study have been previously characterized for their capacity to induce A/E lesions in both explants and challenged pigs, and were grouped according to the severity of the A/E manifestation they produced [13]. Based on their virulence gene content as determined by the E. coli virulence microarray, O45 PEPEC strains and REPEC strain E22 displayed significant differences from typical EPEC and could be regarded as atypical EPEC, that are defined as LEE-positive E. coli lacking stx1 and stx2 genes, as well as the EAF virulence plasmid which encodes the EPEC adhesin BFP [46,47]. In addition, all O45 PEPEC strains and REPEC strain E22 unexpectedly hybridized with the stxB1 probe of the E. coli virulence microarray, as was also observed for some atypical EPEC strains isolated from children with diarrhea in a recent study in Norway [35,48]. Due to the absence of hybridization with the corresponding stxA1 probe and the negative PCR results obtained with stxB1 sequence specific primers [35,48], we therefore concluded that the gene sequences detected by the stxB1 hybridization probe did not represent a complete stxB gene but rather a possible truncated form of this gene. As observed for other atypical EPEC strains, O45 PEPEC strains and REPEC strain E22 also displayed a relatively high heterogeneity in their virulence gene profiles [35,49]. Based on their virulence gene content, they could be divided into two distinct groups, Groups I and II. It has been argued that atypical EPEC strains could have arisen from E. coli strains of different pathotypes which acquired the LEE by horizontal gene transfer or from certain typical EPEC strains that have lost the EAF plasmid [49]. Trabulsi et al. have also observed that some atypical EPEC strains are genetically closer to EHEC strains of serotype O157:H7 than to typical EPEC [50]. Several virulence genes showed a non-random distribution between Group I and Group II strains. Group I strains thus possessed several virulence-related genes which were absent in Group II strains. Group I-specific genes included paa (which contributes to A/E lesion formation in PEPEC strains [10]) and OI#122 genes efa1 (which plays an important role in intestinal colonization by EHEC strains in cattle [51]) and set (which encodes a putative enterotoxin highly similar to the enterotoxin ShET2 of Shigella flexneri). Genes associated with other pathotypes were also found. The gene tsh, encoding a hemagglutinin which may be a virulence factor of avian extraintestinal E. coli [52], the pathogenicity island marker malX, related to virulence in extraintestinal E. coli [53] and the yersiniabactin-related genes fyuA, irp1 and irp2, implicated in the ferric uptake system, were also Group I-specific. In contrast, Group II strains possessed only a few additional virulence-related genes when compared with Group I strains. These included aidaI, which encodes a protein involved in the adherence of EPEC [54], and iron uptake-related genes chuA and fepC. Finally, Group I and Group II strains also possessed different variants of the long polar fimbriae encoding gene lpfA. A recent study has shown that the lpfAO113 variant, found in Group I strains in our study, was found significantly more frequently in atypical EPEC strains associated with cases of diarrhea than in strains isolated from healthy individuals [35]. It is interesting to note that analysis by CGH using a whole genome E. coli microarray, representing two lineage I, human outbreak-related E. coli O157:H7 strains and one non-pathogenic E. coli K12 strain, resulted in the distribution of the O45 PEPEC strains into the same two groups (Groups I and II), observed for the E. coli virulence microarray. This genetic-based grouping, principally reflecting the virulence gene content of the strains, was also compatible with the grouping based on their A/E activity [13]. The O45 PEPEC strains of Group I all induced severe A/E lesions whereas those of Group II induced less severe or no A/E lesions in both pig ileal explants and challenged pigs. REPEC strain E22 was placed into Group I but was genetically distant from the four O45 PEPEC strains belonging to this group. These strains showed a relatively high level of heterogeneity in their virulence gene profiles. In addition to the variations in particular virulence genes, significant variations in GIs were also observed between Group I and II strains. We observed that several virulence-related OIs were present only in Group I strains. These included OI#57 (S-loop#85), which contains the paa gene; OI#71 (S-loop#108), which contains the non-LEE encoded factor gene nleA, previously shown to be associated with the pathogenicity of AEEC strains [34]; and OI#122 which contains the two non-LEE encoded factor genes nleB and nleE and virulence genes efa1 and set. Interestingly, these OIs have also been shown to be more prevalent in STEC strains associated with outbreaks and severe disease [35,36]. On the other hand, certain OIs were only present in Group II strains. These include OI#1 (S-loop#1), containing genes encoding putative fimbrial chaperone proteins; OI#47 (S-loop#71), containing a fimbrial operon and genes encoding several additional putative virulence factors in E. coli of serogroup O157 [55]; and OI#154 (S-loop#253), containing genes encoding putative type 1 fimbrial proteins. Finally, OI#115 was highly divergent between Group I and Group II strains. This OI contains the secondary type III secretion system gene cluster ETT2, which resembles the SPI-1-encoded type III secretion system from Salmonella enterica and has been previously characterized in O157:H7 E. coli strains [16,17]. It has been recently shown that ETT2 influences the secretion of proteins encoded by the LEE and also modulates adhesion to human intestinal cells [56]. Most Group II strains (4/5) possessed the entire ETT2. However, Group II strain ECL2019 lacked most of the entire cluster (only four genes were found to be present) and was one of the two strains which did not induce A/E lesions in explants or in challenged pigs. Group I strains, including REPEC strain E22, have only a partial ETT2 gene cluster, possessing from 15 to 21 genes of the 36 in the intact cluster. The substantial variations observed for this cluster are consistent with the findings of previous studies, that while the ETT2 gene cluster was present in most of the E. coli strains tested, it contained numerous inactivating mutations [31,42,43]. In contrast to the heterogeneity of their virulence gene content and GI distribution, O45 PEPEC strains and REPEC strain E22 showed a high level of homogeneity in their LEE sequences and site of insertion. In all strains, the LEE was inserted into the tRNA pheU gene and no significant divergence between Group I and Group II strains was observed for the LEE genes. In addition, all O45 PEPEC strains and REPEC strain E22 shared the same profile for the intimin encoding gene eae, its translocated receptor tir and the effector encoding genes espA and espB, as shown by the E. coli virulence microarray. All strains possessed the beta variant of the intimin encoding gene, being the most widespread among the intestinal EPEC strains of different animal species [57,58]. However, Group I and Group II strains from our study all belonged to the phylogenetic groups B1 and B2 whereas Ishii et al. have shown that most EPEC strains possessing the intimin subtype beta belong to phylogenetic groups A and B1 [59]. Finally, we have also observed numerous disparities in the distribution of non-LEE encoded genes. Several nle genes were only present in Group I strains whereas others were only found in Group II strains. In addition, Group I and Group II strains possessed two different variants of the genes nleA and nleC. This variation in the distribution of nle genes may influence the pathogenicity of the strains and the type of A/E lesions they produce, since many studies have shown the importance of non-LEE encoded factors in the A/E phenotype [34,41,60,61]. Conclusion We have genetically characterized a collection of O45 PEPEC strains using E. coli O157-E. coli K12 whole genome and virulence gene-specific E. coli microarrays. We have shown that the strains, although showing some heterogeneity, could be classified into two groups, based on their virulence gene and GI content. These differences in their virulence gene content may influence the pathogenicity of O45 PEPEC strains, and explain why Group I O45 PEPEC strains induced more severe A/E lesions in explants and challenged pigs than Group II strains [13,14]. Authors' contributions GB and YZ both contributed equally to the manuscript: they were involved in the conception and design of the study, in the analysis and interpretation of the microarray data, and in drafting and revising the manuscript. PG, JW, and CL were involved in the acquisition of the microarray data and in revising the manuscript. JMF was involved in revising the manuscript critically for important intellectual content. VPJG and JH were involved in the conception and design of the study, and revising the manuscript critically for important intellectual content. All authors read and approved the final manuscript. Additional file 1 Table S1. Primers and E. coli control strains used for PCR experiments. Click here for file(22K, pdf) Additional file 2 Table S2. Presence of virulence genes in O45 PEPEC strains and REPEC strain E22 as determined by E. coli virulence microarray. Click here for file(35K, pdf) Additional file 3 Table S3. Localization of the LEE and OI#122 in O45 PEPEC strains and REPEC strain E22. Click here for file(17K, pdf) Additional file 4 Table S4. Distribution of ETT2 genes in O45 PEPEC strains and REPEC strain E22. Click here for file(16K, pdf) Additional file 5 Table S5. Divergence of genes related to intestinal colonization in bovine and calves as determined by CGH. Click here for file(16K, pdf) Acknowledgements Clarisse Desautels, from the Reference Laboratory for E. coli, Faculté de médecine vétérinaire, Université de Montréal, is greatly acknowledged for her information and her help regarding the collection of O45 PEPEC strains. This work was supported in part by the Natural Sciences and Engineering Research Council of Canada (NSERC) (STPGP 364950), and by the Fond Québécois de la Recherche sur la Nature et les Technologies (FQRNT) (PR-121927). G.B. was supported by a scholarship "Michel Saucier" from Fondation Canadienne Louis Pasteur (FCLP). References
|
PubMed related articles
Your browsing activity is empty. Activity recording is turned off. |
|||||||||||||||
Infect Immun. 1991 Aug; 59(8):2664-72.
[Infect Immun. 1991]Infect Immun. 1993 May; 61(5):2138-44.
[Infect Immun. 1993]Microbiologia. 1991 Sep; 7(2):57-73.
[Microbiologia. 1991]Acta Microbiol Immunol Hung. 1994; 41(3):259-64.
[Acta Microbiol Immunol Hung. 1994]Vet Microbiol. 2002 Mar 1; 85(2):169-82.
[Vet Microbiol. 2002]Science. 1997 Sep 5; 277(5331):1453-62.
[Science. 1997]Nature. 2001 Jan 25; 409(6819):529-33.
[Nature. 2001]DNA Res. 2001 Feb 28; 8(1):11-22.
[DNA Res. 2001]BMC Genomics. 2007 May 16; 8():121.
[BMC Genomics. 2007]Can J Vet Res. 1995 Apr; 59(2):118-23.
[Can J Vet Res. 1995]Mol Microbiol. 1998 Apr; 28(1):1-4.
[Mol Microbiol. 1998]FEMS Microbiol Lett. 1998 Jul 1; 164(1):133-9.
[FEMS Microbiol Lett. 1998]Appl Environ Microbiol. 2006 May; 72(5):3780-4.
[Appl Environ Microbiol. 2006]Infect Immun. 1994 Oct; 62(10):4153-9.
[Infect Immun. 1994]Microb Pathog. 2000 May; 28(5):291-300.
[Microb Pathog. 2000]J Clin Microbiol. 2005 Apr; 43(4):1552-63.
[J Clin Microbiol. 2005]J Clin Microbiol. 1989 Apr; 27(4):743-7.
[J Clin Microbiol. 1989]Infect Immun. 1994 Oct; 62(10):4153-9.
[Infect Immun. 1994]Infect Immun. 1994 Oct; 62(10):4153-9.
[Infect Immun. 1994]J Clin Microbiol. 2005 Apr; 43(4):1552-63.
[J Clin Microbiol. 2005]J Clin Microbiol. 1989 Apr; 27(4):743-7.
[J Clin Microbiol. 1989]Infect Immun. 1994 Oct; 62(10):4153-9.
[Infect Immun. 1994]Science. 1997 Sep 5; 277(5331):1453-62.
[Science. 1997]DNA Res. 2001 Feb 28; 8(1):11-22.
[DNA Res. 2001]Nature. 2001 Jan 25; 409(6819):529-33.
[Nature. 2001]Appl Environ Microbiol. 2006 May; 72(5):3780-4.
[Appl Environ Microbiol. 2006]Appl Environ Microbiol. 2006 May; 72(5):3780-4.
[Appl Environ Microbiol. 2006]Genome Biol. 2002 Oct 29; 3(11):RESEARCH0065.
[Genome Biol. 2002]Biotechniques. 2003 Feb; 34(2):374-8.
[Biotechniques. 2003]FEMS Microbiol Lett. 1998 Jul 1; 164(1):133-9.
[FEMS Microbiol Lett. 1998]Microb Pathog. 2000 May; 28(5):291-300.
[Microb Pathog. 2000]Proc Natl Acad Sci U S A. 1995 Feb 28; 92(5):1664-8.
[Proc Natl Acad Sci U S A. 1995]Int J Med Microbiol. 2003 Feb; 292(7-8):487-93.
[Int J Med Microbiol. 2003]Appl Environ Microbiol. 2006 May; 72(5):3780-4.
[Appl Environ Microbiol. 2006]Appl Environ Microbiol. 2000 Oct; 66(10):4555-8.
[Appl Environ Microbiol. 2000]Appl Environ Microbiol. 2000 Oct; 66(10):4555-8.
[Appl Environ Microbiol. 2000]J Clin Microbiol. 2005 Dec; 43(12):6098-107.
[J Clin Microbiol. 2005]Appl Environ Microbiol. 2000 Oct; 66(10):4555-8.
[Appl Environ Microbiol. 2000]Mol Microbiol. 2004 Mar; 51(5):1233-49.
[Mol Microbiol. 2004]J Clin Microbiol. 2006 Oct; 44(10):3703-11.
[J Clin Microbiol. 2006]J Clin Microbiol. 2003 Nov; 41(11):4930-40.
[J Clin Microbiol. 2003]Biotechniques. 2003 Feb; 34(2):374-8.
[Biotechniques. 2003]Cell Microbiol. 2008 Mar; 10(3):549-56.
[Cell Microbiol. 2008]Microbiology. 2007 Jun; 153(Pt 6):1743-55.
[Microbiology. 2007]Microb Pathog. 2000 May; 28(5):291-300.
[Microb Pathog. 2000]FEMS Microbiol Lett. 1998 Jul 1; 164(1):133-9.
[FEMS Microbiol Lett. 1998]Proc Natl Acad Sci U S A. 1995 Feb 28; 92(5):1664-8.
[Proc Natl Acad Sci U S A. 1995]Int J Med Microbiol. 2003 Feb; 292(7-8):487-93.
[Int J Med Microbiol. 2003]Appl Environ Microbiol. 2006 May; 72(5):3780-4.
[Appl Environ Microbiol. 2006]FEMS Microbiol Lett. 1998 Jul 1; 164(1):133-9.
[FEMS Microbiol Lett. 1998]Microb Pathog. 2000 May; 28(5):291-300.
[Microb Pathog. 2000]Proc Natl Acad Sci U S A. 1995 Feb 28; 92(5):1664-8.
[Proc Natl Acad Sci U S A. 1995]Int J Med Microbiol. 2003 Feb; 292(7-8):487-93.
[Int J Med Microbiol. 2003]Appl Environ Microbiol. 2006 May; 72(5):3780-4.
[Appl Environ Microbiol. 2006]Mol Microbiol. 2004 Mar; 51(5):1233-49.
[Mol Microbiol. 2004]Proc Natl Acad Sci U S A. 2004 Mar 9; 101(10):3597-602.
[Proc Natl Acad Sci U S A. 2004]FEMS Microbiol Lett. 1998 Jul 1; 164(1):133-9.
[FEMS Microbiol Lett. 1998]Microb Pathog. 2000 May; 28(5):291-300.
[Microb Pathog. 2000]Proc Natl Acad Sci U S A. 1995 Feb 28; 92(5):1664-8.
[Proc Natl Acad Sci U S A. 1995]Int J Med Microbiol. 2003 Feb; 292(7-8):487-93.
[Int J Med Microbiol. 2003]J Clin Microbiol. 2003 Jun; 41(6):2341-7.
[J Clin Microbiol. 2003]J Bacteriol. 2004 Jun; 186(11):3547-60.
[J Bacteriol. 2004]DNA Res. 2001 Feb 28; 8(1):11-22.
[DNA Res. 2001]Int J Med Microbiol. 2003 Feb; 292(7-8):487-93.
[Int J Med Microbiol. 2003]FEMS Microbiol Lett. 1998 Jul 1; 164(1):133-9.
[FEMS Microbiol Lett. 1998]Microb Pathog. 2000 May; 28(5):291-300.
[Microb Pathog. 2000]Proc Natl Acad Sci U S A. 1995 Feb 28; 92(5):1664-8.
[Proc Natl Acad Sci U S A. 1995]Microbiology. 2004 Nov; 150(Pt 11):3631-45.
[Microbiology. 2004]Infect Immun. 2005 Mar; 73(3):1735-43.
[Infect Immun. 2005]Infect Immun. 1994 Oct; 62(10):4153-9.
[Infect Immun. 1994]Vet Microbiol. 2006 Apr 16; 114(1-2):82-93.
[Vet Microbiol. 2006]J Clin Microbiol. 2006 Oct; 44(10):3703-11.
[J Clin Microbiol. 2006]J Clin Microbiol. 2008 Jul; 46(7):2280-90.
[J Clin Microbiol. 2008]J Clin Microbiol. 2006 Oct; 44(10):3703-11.
[J Clin Microbiol. 2006]J Infect Dis. 2001 Mar 1; 183(5):762-72.
[J Infect Dis. 2001]Emerg Infect Dis. 2002 May; 8(5):508-13.
[Emerg Infect Dis. 2002]Infect Immun. 2003 Aug; 71(8):4516-25.
[Infect Immun. 2003]Mol Microbiol. 2000 Jan; 35(2):275-88.
[Mol Microbiol. 2000]Infect Immun. 1994 Oct; 62(10):4153-9.
[Infect Immun. 1994]Mol Microbiol. 2004 Mar; 51(5):1233-49.
[Mol Microbiol. 2004]J Clin Microbiol. 2006 Oct; 44(10):3703-11.
[J Clin Microbiol. 2006]J Clin Microbiol. 2003 Nov; 41(11):4930-40.
[J Clin Microbiol. 2003]J Clin Microbiol. 2005 Aug; 43(8):3840-50.
[J Clin Microbiol. 2005]DNA Res. 2001 Feb 28; 8(1):11-22.
[DNA Res. 2001]Infect Immun. 2000 Jan; 68(1):64-71.
[Infect Immun. 2000]Vet Microbiol. 2005 Mar 20; 106(1-2):87-95.
[Vet Microbiol. 2005]Appl Environ Microbiol. 2007 Sep; 73(18):5703-10.
[Appl Environ Microbiol. 2007]Mol Microbiol. 2004 Mar; 51(5):1233-49.
[Mol Microbiol. 2004]Proc Natl Acad Sci U S A. 2004 Mar 9; 101(10):3597-602.
[Proc Natl Acad Sci U S A. 2004]Infect Immun. 2006 Apr; 74(4):2328-37.
[Infect Immun. 2006]Microbiology. 2007 May; 153(Pt 5):1350-60.
[Microbiology. 2007]Infect Immun. 1994 Oct; 62(10):4153-9.
[Infect Immun. 1994]Can J Vet Res. 1995 Apr; 59(2):118-23.
[Can J Vet Res. 1995]